Ulf Eriksson

Articles in Scholarly Journals [Incomplete List]

  1. Suramin-Restricted Blood Volume in the Placenta of Normal and Diabetic Rats is Normalized by Vitamin E Treatment
    Placenta, vol. 28, no. 5-6, pp. 505–515, 2007
  2. Exposure of neural crest cells to elevated glucose leads to congenital heart defects, an effect that can be prevented by N-acetylcysteine
    Birth Defects Research Part A: Clinical and Molecular Teratology, vol. 79, no. 3, pp. 231–235, 2007
  3. Folic acid supplementation affects ROS scavenging enzymes, enhances Vegf-A, and diminishes apoptotic state in yolk sacs of embryos of diabetic rats?
    Reproductive Toxicology, vol. 23, no. 4, pp. 486–498, 2007
  4. Maternal diabetes in vivo and high glucose concentration in vitro increases apoptosis in rat embryos
    Reproductive Toxicology, vol. 23, no. 1, pp. 63–74, 2007
  5. Combined supplementation of folic acid and vitamin E diminishes diabetes-induced embryotoxicity in rats
    Birth Defects Research Part A: Clinical and Molecular Teratology, vol. 76, no. 6, pp. 483–490, 2006
  6. Understanding Retinol Metabolism: Structure and Function of Retinol Dehydrogenases
    Journal of Biological Chemistry, vol. 281, no. 19, pp. 13001–13004, 2006
  7. Antioxidative Treatment Diminishes Ethanol-Induced Congenital Malformations in the Rat
    Alcoholism: Clinical and Experimental Research, vol. 30, no. 10, pp. 1752–1760, 2006
  8. Ethanol-Induced Fetal Dysmorphogenesis in the Mouse Is Diminished by High Antioxidative Capacity of the Mother
    Toxicological Sciences, vol. 92, no. 2, pp. 416–422, 2006
  9. Experimental Intrauterine Growth Retardation in the Rat Causes a Reduction of Pancreatic B-Cell Mass, Which Persists into Adulthood
    Biology of the Neonate, vol. 88, no. 2, pp. 122–128, 2005
  10. Structural Requirements for Activation of Latent Platelet-derived Growth Factor CC by Tissue Plasminogen Activator
    Journal of Biological Chemistry, vol. 280, no. 29, pp. 26856–26862, 2005
  11. Gene Transfers of Vascular Endothelial Growth Factor-A, Vascular Endothelial Growth Factor-B, Vascular Endothelial Growth Factor-C, and Vascular Endothelial Growth Factor-D Have No Effects on Atherosclerosis in Hypercholesterolemic Low-Density Lipoprotein-Receptor/Apolipoprotein B48-Deficient Mice
    Circulation, vol. 112, no. 9, pp. 1347–1352, 2005
  12. Platelet-Derived Growth Factor D Induces Cardiac Fibrosis and Proliferation of Vascular Smooth Muscle Cells in Heart-Specific Transgenic Mice
    Circulation Research, vol. 97, no. 10, pp. 1036–1045, 2005
  13. Revascularization of ischemic tissues by PDGF-CC via effects on endothelial cells and their progenitors
    Journal of Clinical Investigation, vol. 115, no. 1, pp. 118–127, 2005
  14. Development of a versatile reporter assay for studies of retinol uptake and metabolism in vivo
    Experimental Cell Research, vol. 310, no. 2, pp. 401–408, 2005
  15. Placental dysfunction in Suramin-treated rats: Impact of maternal diabetes and effects of antioxidative treatment
    Journal of the Society for Gynecologic Investigation, vol. 12, no. 3, pp. 174–184, 2005
  16. Placental dysfunction in Suramin-treated rats ? a new model for pre-eclampsia
    Placenta, vol. 26, no. 5, pp. 410–418, 2005
  17. A diabetes-like environment increases malformation rate and diminishes prostaglandin E2 in rat embryos: Reversal by administration of vitamin E and folic acid
    Birth Defects Research Part A: Clinical and Molecular Teratology, vol. 73, no. 7, pp. 506–511, 2005
  18. Antioxidative treatment of pregnant diabetic rats diminishes embryonic dysmorphogenesis
    Birth Defects Research Part A: Clinical and Molecular Teratology, vol. 73, no. 7, pp. 498–505, 2005
  19. The C-terminal region of cis-retinol/androgen dehydrogenase 1 (CRAD1) confers ER localization and in vivo enzymatic function
    Experimental Cell Research, vol. 311, no. 2, pp. 205–217, 2005
  20. Disturbed morphogenesis of cardiac outflow tract and increased rate of aortic arch anomalies in the offspring of diabetic rats
    Birth Defects Research Part A: Clinical and Molecular Teratology, vol. 70, no. 12, pp. 927–938, 2004
  21. The PDGF family: four gene products form five dimeric isoforms
    Cytokine & Growth Factor Reviews, vol. 15, no. 4, pp. 197–204, 2004
  22. Tissue plasminogen activator is a potent activator of PDGF-CC
    The EMBO Journal, vol. 23, no. 19, Article ID 7600397, 9 pages, 2004
  23. Folic Acid Supplementation Diminishes Diabetes- and Glucose-Induced Dysmorphogenesis in Rat Embryos In Vivo and In Vitro
    Diabetes, vol. 54, no. 2, pp. 546–553, 2004
  24. PDGF-D induces macrophage recruitment, increased interstitial pressure, and blood vessel maturation during angiogenesis
    Blood, vol. 104, no. 10, pp. 3198–3204, 2004
  25. Platelet-Derived Growth Factor Production by B16 Melanoma Cells Leads to Increased Pericyte Abundance in Tumors and an Associated Increase in Tumor Growth Rate
    Cancer Research, vol. 64, no. 8, pp. 2725–2733, 2004
  26. PDGF-D is a potent transforming and angiogenic growth factor
    Oncogene, vol. 22, no. 10, Article ID 1206223, 9 pages, 2003
  27. Maternal Diabetes In Vivo and High Glucose In Vitro Diminish GAPDH Activity in Rat Embryos
    Diabetes, vol. 52, no. 5, pp. 1222–1228, 2003
  28. PDGF-C Expression in the Developing and Normal Adult Human Kidney and in Glomerular Diseases
    Journal of the American Society of Nephrology, vol. 14, no. 5, pp. 1145–1153, 2003
  29. Novel PDGF family members: PDGF-C and PDGF-D
    Cytokine & Growth Factor Reviews, vol. 14, no. 2, pp. 91–98, 2003
  30. Reviews in Endocrine and Metabolic Disorders, vol. 4, no. 1, pp. 79–93, 2003
  31. Structure and function of retinol dehydrogenases of the short chain dehydrogenase/reductase family
    Molecular Aspects of Medicine, vol. 24, no. 6, pp. 403–409, 2003
  32. Role of vascular endothelial growth factor and placental growth factor in basal adhesion formation and in carbon dioxide pneumoperitoneum-enhanced adhesion formation after laparoscopic surgery in transgenic mice*1
    Fertility and Sterility, vol. 80, pp. 803–811, 2003
  33. Vascular endothelial growth factor (VEGF) receptor-2 signaling mediates VEGF-C?N?C- and VEGF-A-induced angiogenesis in vitro
    Experimental Cell Research, vol. 285, no. 2, pp. 286–298, 2003
  34. Maternal diabetes in the rat impairs the formation of neural-crest derived cranial nerve ganglia in the offspring
    Diabetologia, vol. 46, no. 9, pp. 1245–1251, 2003
  35. New Members of the Platelet-Derived Growth Factor Family of Mitogens
    Archives of Biochemistry and Biophysics, vol. 398, no. 2, pp. 284–290, 2002
  36. 8-Iso-PGF2? administration generates dysmorphogenesis and increased lipid peroxidation in rat embryos in vitro
    Teratology, vol. 66, no. 4, pp. 164–168, 2002
  37. Expression analysis of PDGF-C in adult and developing mouse tissues
    Mechanisms of Development, vol. 110, no. 1-2, pp. 187–191, 2002
  38. VEGF receptor 1 stimulates stem-cell recruitment and new hope for angiogenesis therapies
    Nature Medicine, vol. 8, no. 8, Article ID nm0802-775, 2 pages, 2002
  39. Novel VEGF family members: VEGF-B, VEGF-C and VEGF-D
    The International Journal of Biochemistry & Cell Biology, vol. 33, no. 4, pp. 421–426, 2001
  40. Increased rate of lipid peroxidation and protein carbonylation in experimental diabetic pregnancy
    Diabetologia, vol. 44, no. 6, pp. 766–774, 2001
  41. The Drosophila VEGF receptor homolog is expressed in hemocytes
    Mechanisms of Development, vol. 109, no. 1, pp. 69–77, 2001
  42. Induction of embryonic dysmorphogenesis by high glucose concentration, disturbed inositol metabolism, and inhibited protein kinase C activity
    Teratology, vol. 63, no. 5, pp. 193–201, 2001
  43. More on the diabetic embryopathy
    Teratology, vol. 63, no. 3, pp. 114–115, 2001
  44. Increased Retinoid Signaling in Vascular Smooth Muscle Cells by Proinflammatory Cytokines
    Biochemical and Biophysical Research Communications, vol. 286, no. 2, pp. 336–342, 2001
  45. Nature Cell Biology, vol. 3, no. 5, pp. 512–516, 2001
  46. Nature Medicine, vol. 7, no. 5, pp. 575–583, 2001
  47. Biosynthesis of 9-cis-Retinoic Acid in Vivo. THE ROLES OF DIFFERENT RETINOL DEHYDROGENASES AND A STRUCTURE-ACTIVITY ANALYSIS OF MICROSOMAL RETINOL DEHYDROGENASES
    Journal of Biological Chemistry, vol. 276, no. 22, pp. 19253–19258, 2001
  48. Biochemical Defects in 11-cis-Retinol Dehydrogenase Mutants Associated with Fundus Albipunctatus
    Journal of Biological Chemistry, vol. 276, no. 52, pp. 49251–49257, 2001
  49. Purification, Characterization, and Biological Compartmentalization of Rat Fetal Antigen 1
    Biology of Reproduction, vol. 63, no. 1, pp. 30–33, 2000
  50. Increased mRNA levels of Mn-SOD and catalase in embryos of diabetic rats from a malformation-resistant strain
    Diabetes, vol. 49, no. 1, pp. 101–107, 2000
  51. Gene Structure, Expression Analysis, and Membrane Topology of RDH4
    Experimental Cell Research, vol. 256, no. 1, pp. 338–345, 2000
  52. Nature Cell Biology, vol. 2, no. 5, pp. 302–309, 2000
  53. Malformations in offspring of diabetic rats: Morphometric analysis of neural crest-derived organs and effects of maternal vitamin E treatment
    Teratology, vol. 61, no. 5, pp. 355–367, 2000
  54. CRBP I and CRABP I localisation during olfactory nerve development
    Developmental Brain Research, vol. 114, no. 1, pp. 121–126, 1999
  55. Localization of VEGF-B in the mouse embryo suggests a paracrine role of the growth factor in the developing vasculature
    Developmental Dynamics, vol. 215, no. 1, pp. 12–25, 1999
  56. Nature Genetics, vol. 22, no. 2, pp. 188–191, 1999
  57. Activity of human 11-cis-retinol dehydrogenase (Rdh5) with steroids and retinoids and expression of its mRNA in extra-ocular human tissue
    Biochemical Journal, vol. 338, no. 1, p. 23, 1999
  58. Hyperglycemia-induced embryonic dysmorphogenesis correlates with genomic DNA mutation frequency in vitro and in vivo
    Diabetes, vol. 48, no. 2, pp. 371–376, 1999
  59. Developmental damage, increased lipid peroxidation, diminished cyclooxygenase-2 gene expression, and lowered prostaglandin E2 levels in rat embryos exposed to a diabetic environment
    Diabetes, vol. 48, no. 4, pp. 813–820, 1999
  60. Current biology of VEGF-B and VEGF-C
    Current Opinion in Biotechnology, vol. 10, no. 6, pp. 528–538, 1999
  61. Differential Binding of Vascular Endothelial Growth Factor B Splice and Proteolytic Isoforms to Neuropilin-1
    Journal of Biological Chemistry, vol. 274, no. 30, pp. 21217–21222, 1999
  62. Nature Medicine, vol. 5, no. 7, pp. 715–715, 1999
  63. Appearance of glucose-induced insulin release in fetal rat beta-cells
    Journal of Endocrinology, vol. 158, no. 1, pp. 115–120, 1998
  64. Teratogenicity of 3-deoxyglucosone and diabetic embryopathy
    Diabetes, vol. 47, no. 12, pp. 1960–1966, 1998
  65. Antioxidants diminish developmental damage induced by high glucose and cyclooxygenase inhibitors in rat embryos in vitro
    Diabetes, vol. 47, no. 4, pp. 677–684, 1998
  66. Maternal diabetes alters extracellular matrix protein levels in rat placentasâ??, â??â??, â??, â??â??
    American Journal of Obstetrics and Gynecology, vol. 179, no. 3, pp. 772–778, 1998
  67. The identification of a 9-cis retinol dehydrogenase in the mouse embryo reveals a pathway for synthesis of 9-cis retinoic acid
    Proceedings of the National Academy of Sciences, vol. 95, no. 8, pp. 4404–4409, 1998
  68. Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells
    Proceedings of the National Academy of Sciences, vol. 95, no. 20, pp. 11709–11714, 1998
  69. Panhypopituitarism, neurosensory deafness and Noonanâ??s syndrome in a child of a diabetic mother: role of maternal hypoglycaemia during pregnancy in induction of congenital lesions
    Diabetic Medicine, vol. 15, no. 7, pp. 620–621, 1998
  70. Maternal antioxidant treatments prevent diabetes-induced alterations of mitochondrial morphology in rat embryos
    The Anatomical Record, vol. 251, no. 3, pp. 303–315, 1998
  71. METABOLIC ALTERATIONS IN NEURAL TISSUE OF RAT EMBRYOS EXPOSED TO ß-HYDROXYBUTYRATE DURING ORGANOGENESIS
    Life Sciences, vol. 62, no. 4, pp. 293–300, 1997
  72. The NH2-terminal amino acid sequence of cellular retinoic-acid binding protein from rat testis
    FEBS Letters, vol. 135, no. 1, pp. 70–72, 1981
  73. STRUCTURAL AND FUNCTIONAL STUDIES OF VITAMIN A-BINDING PROTEINS
    Annals of the New York Academy of Sciences, vol. 359, no. 1 Modulation of, pp. 79–90, 1981